Association Between Artificial Intelligence-Detected Features on the ECG and Presence of Microvascular Obstruction

Area of Science:

• Cardiology
• Cardiovascular Imaging
• Interventional Cardiology

Background:

• Microvascular obstruction (MVO) after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is linked to adverse left-ventricular remodeling, increased major adverse cardiac events, and mortality.
• MVO mechanisms include distal embolization and microvascular dysfunction, alongside interstitial edema compressing the microcirculation due to ischemia-reperfusion injury.
• Current gold standard for MVO detection, cardiac MRI (CMR), is costly, time-intensive, and not widely accessible at STEMI centers.

Purpose of the Study:

• To highlight the clinical significance of identifying MVO in STEMI patients.
• To emphasize the need for non-CMR methods for MVO detection to guide patient management and clinical trial outcomes.
• To underscore the prognostic implications of MVO in STEMI, guiding the selection of high-risk patients for intensive therapy and novel therapeutics.

Main Methods:

• Review of existing literature on microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI).
• Discussion of the pathophysiology and diagnostic challenges of MVO.
• Exploration of the prognostic impact of MVO and potential alternative detection methods.

Main Results:

• MVO presence post-PCI in STEMI is a significant predictor of poor prognosis.
• MVO is associated with detrimental left-ventricular remodeling and increased adverse cardiac events and mortality.
• Non-CMR methods for MVO detection are needed for broader clinical application and research.

Conclusions:

• Identifying MVO is critical for risk stratification in STEMI patients.
• Accessible MVO detection methods are essential for optimizing patient care and evaluating new treatments.
• Further research into non-invasive MVO detection could improve outcomes for high-risk STEMI patients.